Question follow-through · 66231
Radioisotopes
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the (a) availability and (b) supply of medical radionuclides for NHS use in the next (i) 5, (ii) 10, (iii) 15 and (iv) 20 years.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 9 Jul 2025
- Target answer date
- 11 Jul 2025
- Answer
- 15 Jul 2025 · 6 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
9 Jul 2025
Question tabled
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the (a) availability and (b) supply of medical radionuclides for NHS use in the next (i) 5, (ii) 10, (iii) 15 and (iv) 20 years.
11 Jul 2025
Target answer date
Date supplied by the official written-questions record.
15 Jul 2025
Answer published
The Department has not made a specific assessment. The Department regularly engages with suppliers, specialist clinicians, the British Nuclear Medicine Society, and the UK Radiopharmacy Group to support the continued supply of medical radioisotopes for Na...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
No later same-department questions indexed.
This is an absence in covered public data, not evidence that no follow-up occurred elsewhere.